NO930884L - Antimikrobielle karbapenemderivater, samt fremgangsmaate til fremstilling og terapeutisk anvendelse derav - Google Patents

Antimikrobielle karbapenemderivater, samt fremgangsmaate til fremstilling og terapeutisk anvendelse derav

Info

Publication number
NO930884L
NO930884L NO93930884A NO930884A NO930884L NO 930884 L NO930884 L NO 930884L NO 93930884 A NO93930884 A NO 93930884A NO 930884 A NO930884 A NO 930884A NO 930884 L NO930884 L NO 930884L
Authority
NO
Norway
Prior art keywords
carbape
antimicrobial
procedures
derivatives
manufacturing
Prior art date
Application number
NO93930884A
Other languages
English (en)
Other versions
NO930884D0 (no
NO303730B1 (no
Inventor
Isao Kawamoto
Rokuro Endo
Masao Miyauchi
Katsuya Ishikawa
Katsuhiko Watanabe
Hiroshi Yasuda
Satoshi Ohya
Yukio Utsui
Original Assignee
Sankuo Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankuo Company Limited filed Critical Sankuo Company Limited
Publication of NO930884D0 publication Critical patent/NO930884D0/no
Publication of NO930884L publication Critical patent/NO930884L/no
Publication of NO303730B1 publication Critical patent/NO303730B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
NO930884A 1992-03-11 1993-03-11 Antimikrobielle karbapenemderivater NO303730B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP5216392 1992-03-11
JP24495392 1992-09-14
JP24657892 1992-09-16

Publications (3)

Publication Number Publication Date
NO930884D0 NO930884D0 (no) 1993-03-11
NO930884L true NO930884L (no) 1993-09-13
NO303730B1 NO303730B1 (no) 1998-08-24

Family

ID=27294566

Family Applications (1)

Application Number Title Priority Date Filing Date
NO930884A NO303730B1 (no) 1992-03-11 1993-03-11 Antimikrobielle karbapenemderivater

Country Status (19)

Country Link
EP (1) EP0560613B1 (no)
KR (1) KR100258225B1 (no)
CN (1) CN1037180C (no)
AT (1) ATE173733T1 (no)
AU (1) AU664422B2 (no)
CA (1) CA2091486A1 (no)
CZ (1) CZ290002B6 (no)
DE (1) DE69322188T2 (no)
DK (1) DK0560613T3 (no)
ES (1) ES2125945T3 (no)
FI (1) FI103046B1 (no)
HK (1) HK1011976A1 (no)
HU (1) HU218676B (no)
IL (1) IL105020A (no)
MX (1) MX9301361A (no)
NO (1) NO303730B1 (no)
NZ (1) NZ247129A (no)
RU (1) RU2097383C1 (no)
TW (1) TW249803B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2093514C1 (ru) * 1991-06-04 1997-10-20 Санкио Компани Лимитед Производные 1-метилкарбапенема и способ их получения
GB9515975D0 (en) 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
NZ324447A (en) * 1995-12-21 1999-08-30 Sankyo Co 1-methyl-carbapenem substituted by a 4-pyrrolidinylthio group and medicaments
WO1997041123A1 (fr) * 1996-04-26 1997-11-06 Sankyo Company, Limited Derives de 1-methylcarbapeneme
WO1998007692A1 (en) 1996-08-17 1998-02-26 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
AU1415500A (en) * 1998-12-07 2000-06-26 Sankyo Company Limited 1-methylcarbapenem derivatives
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
GB9930317D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930318D0 (en) 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
ES2368997T3 (es) * 2001-09-26 2011-11-24 Merck Sharp & Dohme Corp. Procedimiento de fabricación de compuestos de carbapenem.
US7511159B2 (en) 2003-12-25 2009-03-31 Ono Pharmaceutical Co., Ltd. Azetidine ring compounds and drugs comprising the same
CN101367814B (zh) * 2007-06-28 2010-12-15 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰哌啶取代的培南衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
ES2051700T3 (es) * 1986-03-27 1994-07-01 Sumitomo Pharma Un proceso para la preparacion de un compuesto beta-lactama.
CA2036163C (en) * 1990-02-14 2001-06-19 Makoto Sunagawa Novel beta-lactam compounds and their production
IE910606A1 (en) * 1990-02-23 1991-08-28 Sankyo Co Carbapenem derivatives having antibiotic activity, their¹preparation and their use
GB9107363D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
RU2093514C1 (ru) * 1991-06-04 1997-10-20 Санкио Компани Лимитед Производные 1-метилкарбапенема и способ их получения
WO1993021186A1 (en) * 1992-04-13 1993-10-28 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents

Also Published As

Publication number Publication date
HU9300677D0 (en) 1993-05-28
DE69322188D1 (de) 1999-01-07
HK1011976A1 (en) 1999-07-23
EP0560613B1 (en) 1998-11-25
HUT64071A (en) 1993-11-29
FI103046B (fi) 1999-04-15
DE69322188T2 (de) 1999-07-29
CN1079472A (zh) 1993-12-15
KR100258225B1 (ko) 2000-08-01
ATE173733T1 (de) 1998-12-15
AU664422B2 (en) 1995-11-16
NZ247129A (en) 1994-09-27
DK0560613T3 (da) 1999-08-09
FI103046B1 (fi) 1999-04-15
CZ39393A3 (en) 1993-12-15
IL105020A (en) 1997-04-15
CN1037180C (zh) 1998-01-28
NO930884D0 (no) 1993-03-11
FI931079A0 (fi) 1993-03-10
CA2091486A1 (en) 1993-09-12
HU218676B (hu) 2000-10-28
TW249803B (no) 1995-06-21
MX9301361A (es) 1994-01-31
FI931079A (fi) 1993-09-12
AU3515193A (en) 1993-09-16
RU2097383C1 (ru) 1997-11-27
CZ290002B6 (cs) 2002-05-15
KR930019674A (ko) 1993-10-18
ES2125945T3 (es) 1999-03-16
IL105020A0 (en) 1993-07-08
EP0560613A1 (en) 1993-09-15
NO303730B1 (no) 1998-08-24

Similar Documents

Publication Publication Date Title
ATE168992T1 (de) 7-substituierte-9-substituierte glycylamido-6- demethyl-6-deoxytetracycline
ATE215530T1 (de) 7-substituierte-8-substituierte-9-substituierte amino-7-demethyl-6-deoxy-tetracycline als antibiotische mittel
PH30006A (en) 9-¬(Substituted glycol)amido¾-6.demethyl-6-deoxytetra-cyclines
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
FI935555A0 (fi) Nya sulfonamider
FI893433A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
NO930884D0 (no) Antimikrobielle karbapenemderivater, samt fremgangsmaate til fremstilling og terapeutisk anvendelse derav
AU667593B2 (en) Inhibitors of HIV protease useful for the treatment of AIDS
DE69431035T2 (de) 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression
RU93004678A (ru) Противомикробные производные карбапенема, способы их получения и применение
GR3022604T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
AU6029090A (en) Improvements in or relating to organic compounds
EE9400233A (et) 1,5,6,7-tetrahüdro-4H-indasool-4-ooni sisaldav ravim, uus 1,5,6,7-tetrahüdro-4H-indasool-4-oon ja meetodid nende saamiseks

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN SEPTEMBER 2003